IL10 and infection: MAP infection studies are still needed to clearly enumerate quantitatively the trade-off between the benefits of Th1 responses accompanied by the inflammation and the cost (potential disease pathology) of IL-10 Th1 suppression and to provide clear interpretation whether at the animal level IL-10 indeed confers protection while at the site of infection favours pathology.